CARING PHARMACY GROUP BERHAD
KLSE (MYR): CARING (5245)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.58
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Financial
Market Cap
562 Million
NOSH
218 Million
Latest Quarter
30-Nov-2019 [#2]
Announcement Date
22-Jan-2020
Next Quarter
29-Feb-2020
Est. Ann. Date
25-Apr-2020
Est. Ann. Due Date
29-Apr-2020
QoQ | YoY
18.54% | -13.66%
Revenue | NP to SH
626,660.000 | 20,035.000
RPS | P/RPS
287.85 Cent | 0.90
EPS | P/E | EY
9.20 Cent | 28.04 | 3.57%
DPS | DY | Payout %
6.00 Cent | 2.33% | 65.20%
NAPS | P/NAPS
0.67 | 3.85
QoQ | YoY
-3.77% | -3.95%
NP Margin | ROE
3.91% | 13.74%
F.Y. | Ann. Date
30-Nov-2019 | 22-Jan-2020
Latest Audited Result
31-May-2017
Announcement Date
29-Sep-2017
Next Audited Result
31-May-2018
Est. Ann. Date
29-Sep-2018
Est. Ann. Due Date
27-Nov-2018
Revenue | NP to SH
599,234.000 | 20,728.000
RPS | P/RPS
275.25 Cent | 0.94
EPS | P/E | EY
9.52 Cent | 27.10 | 3.69%
DPS | DY | Payout %
5.00 Cent | 1.94% | 52.52%
NAPS | P/NAPS
0.70 | 3.69
YoY
11.68%
NP Margin | ROE
4.28% | 13.60%
F.Y. | Ann. Date
31-May-2019 | 25-Jul-2019
Revenue | NP to SH
660,338.000 | 18,274.000
RPS | P/RPS
303.32 Cent | 0.85
EPS | P/E | EY
8.40 Cent | 30.74 | 3.25%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
9.27% | -7.03%
NP Margin | ROE
3.24% | 12.53%
F.Y. | Ann. Date
30-Nov-2019 | 22-Jan-2020
Show?
| Last 10 FY Result | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 660,338 | 626,660 | 599,234 | 508,270 | 459,957 | 402,569 | 366,699 | 338,337 | 0 | - | |
| PBT | 28,878 | 32,168 | 33,965 | 29,566 | 21,953 | 12,231 | 18,499 | 22,810 | 0 | - | |
| Tax | -7,508 | -7,687 | -8,316 | -6,242 | -5,164 | -3,680 | -5,482 | -6,534 | 0 | - | |
| NP | 21,370 | 24,481 | 25,649 | 23,324 | 16,789 | 8,551 | 13,017 | 16,276 | 0 | - | |
| - | |||||||||||
| NP to SH | 18,274 | 20,035 | 20,728 | 18,560 | 13,130 | 7,289 | 12,869 | 15,078 | 0 | - | |
| - | |||||||||||
| Tax Rate | 26.00% | 23.90% | 24.48% | 21.11% | 23.52% | 30.09% | 29.63% | 28.65% | - | - | |
| Total Cost | 638,968 | 602,179 | 573,585 | 484,946 | 443,168 | 394,018 | 353,682 | 322,061 | 0 | - | |
| - | |||||||||||
| Net Worth | 145,863 | 145,863 | 152,394 | 143,686 | 130,623 | 121,915 | 119,738 | 113,207 | 0 | - | |
| Equity | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Worth | 145,863 | 145,863 | 152,394 | 143,686 | 130,623 | 121,915 | 119,738 | 113,207 | 0 | - | |
| NOSH | 217,706 | 217,706 | 217,706 | 217,706 | 217,706 | 217,706 | 217,706 | 217,706 | 0 | - | |
| Ratio Analysis | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NP Margin | 3.24% | 3.91% | 4.28% | 4.59% | 3.65% | 2.12% | 3.55% | 4.81% | 0.00% | - | |
| ROE | 12.53% | 13.74% | 13.60% | 12.92% | 10.05% | 5.98% | 10.75% | 13.32% | 0.00% | - | |
| Per Share | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RPS | 303.32 | 287.85 | 275.25 | 233.47 | 211.27 | 184.91 | 168.44 | 155.41 | 0.00 | - | |
| EPS | 8.40 | 9.20 | 9.52 | 8.53 | 6.03 | 3.35 | 5.91 | 7.47 | 0.00 | - | |
| DPS | 12.00 | 6.00 | 5.00 | 5.00 | 3.00 | 1.50 | 2.00 | 3.00 | 0.00 | - | |
| NAPS | 0.67 | 0.67 | 0.70 | 0.66 | 0.60 | 0.56 | 0.55 | 0.52 | 0.00 | - | |
| Adjusted Per Share Value based on latest NOSH - 217,706 | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RPS | 303.32 | 287.85 | 275.25 | 233.47 | 211.27 | 184.91 | 168.44 | 155.41 | 0.00 | - | |
| EPS | 8.40 | 9.20 | 9.52 | 8.53 | 6.03 | 3.35 | 5.91 | 7.47 | 0.00 | - | |
| DPS | 12.00 | 6.00 | 5.00 | 5.00 | 3.00 | 1.50 | 2.00 | 3.00 | 0.00 | - | |
| NAPS | 0.67 | 0.67 | 0.70 | 0.66 | 0.60 | 0.56 | 0.55 | 0.52 | 0.00 | - | |
| Price Multiplier on Financial Quarter End Date | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | 29/11/19 | 29/11/19 | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 29/05/15 | 30/05/14 | - | - | |
| Price | 2.51 | 2.51 | 1.92 | 1.55 | 1.81 | 1.75 | 1.00 | 2.11 | 0.00 | - | |
| P/RPS | 0.83 | 0.87 | 0.70 | 0.66 | 0.86 | 0.95 | 0.59 | 1.36 | 0.00 | - | |
| P/EPS | 29.90 | 27.27 | 20.17 | 18.18 | 30.01 | 52.27 | 16.92 | 30.47 | 0.00 | - | |
| EY | 3.34 | 3.67 | 4.96 | 5.50 | 3.33 | 1.91 | 5.91 | 3.28 | 0.00 | - | |
| DY | 4.78 | 2.39 | 2.60 | 3.23 | 1.66 | 0.86 | 2.00 | 1.42 | 0.00 | - | |
| P/NAPS | 3.75 | 3.75 | 2.74 | 2.35 | 3.02 | 3.13 | 1.82 | 4.06 | 0.00 | - | |
| Price Multiplier on Announcement Date | |||||||||||
| AQR | T4Q | 31/05/19 | 31/05/18 | 31/05/17 | 31/05/16 | 31/05/15 | 31/05/14 | 31/05/13 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | 22/01/20 | 22/01/20 | 25/07/19 | 24/07/18 | 27/07/17 | 29/07/16 | 28/07/15 | 31/07/14 | - | - | |
| Price | 2.52 | 2.52 | 1.90 | 1.65 | 1.70 | 1.67 | 1.10 | 2.14 | 0.00 | - | |
| P/RPS | 0.83 | 0.88 | 0.69 | 0.71 | 0.80 | 0.90 | 0.65 | 1.38 | 0.00 | - | |
| P/EPS | 30.02 | 27.38 | 19.96 | 19.35 | 28.19 | 49.88 | 18.61 | 30.90 | 0.00 | - | |
| EY | 3.33 | 3.65 | 5.01 | 5.17 | 3.55 | 2.00 | 5.37 | 3.24 | 0.00 | - | |
| DY | 4.76 | 2.38 | 2.63 | 3.03 | 1.76 | 0.90 | 1.82 | 1.40 | 0.00 | - | |
| P/NAPS | 3.76 | 3.76 | 2.71 | 2.50 | 2.83 | 2.98 | 2.00 | 4.12 | 0.00 | - | |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
2 people like this. Showing 50 of 383 comments
It's going up time to buy ! Come on gaiss.
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp
2019-08-26 10:54
Pharmaniaga’s focus on non-concession ops seen to boost profit
https://www.klsescreener.com/v2/news/view/572140
2019-08-28 10:04
Morning!
Something good to read in the morning.
"High time to decide on concession issue"
Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp
2019-08-30 09:08
WOW!!
The positive long-term outlook for Pharmaniaga
Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp
2019-09-05 13:10
DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.
Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp
2019-09-11 10:56
“The big problem is price control, not Pharmaniaga,” says MyCC
Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.
Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
2019-09-13 09:53
The public need to understand that Pharmaniaga's role as a concessionaire and not immediately liken it to a monopoly. Shared some thoughts in this article (https://klse.i3investor.com/blogs/MYpharmaceuticalnews/228733.jsp). Though it could use a bit more context but hope this can get the conversation going.
Source: http://read.focusmalaysia.my/ePaper/xml_epaper/Focus/05_10_2019/pla_1_Standard/xml_arts/art_52429.htm
2019-10-07 16:23
Overall, Caring has raised its cash balance from RM 77.9 million in 2013 to RM 131.3 million in 2019. Hence, Caring has built itself a solid record of bringing in positive cash flows from operations and opted to split the proceeds half for CAPEX and dividend payments and the remaining half to be retained within its bank account during the period.
2019-10-21 16:03
Caring has expanded its store network from 46 in 2010 to having a total of 125 outlets in 2019.
As of 1 October 2019, Caring is worth RM 446.30 million in market capitalisation. On 30 August 2019, Caring’s three largest shareholders are as follows:
a.) Motivasi Optima Sdn Bhd - 50.35% - Chong Yeow Siang, Soo Chan Chiew, Tan Lean Boon and Ang Khoon Lim are substantial shareholders of Caring through their stakes in MOSB. As I write, they are members of the company’s board of directors.
b.) Perbadanan Nasional Bhd - 9.61%
c.) Jitumaju Sdn Bhd - 5.29%
Tan Sri Dato’ Seri Vincent Tan Chee Yioun is a substantial shareholder of Caring with a total of 8.90% indirect shareholdings where his stakes are in Jitumaju, U Telemedia Sdn Bhd & Convenience Shopping (Sabah) Sdn Bhd presently.
Five Years Transformation Plan
Caring is embarking on a five-year transformation plan starting in 2020, where it intends to increase its revenue from around RM 600 million in 2019 to as high as RM 1 billion by 2024.
From 2014 to 2019, Caring has generated RM 125.2 million in positive cash flows from operations, RM 11.6 million;interest income and RM 43.8 million from the IPO listing.
Out of RM125.2 million, the compnay has spent RM 35.4 million in net capital expenditures (CAPEX) and RM 31.6 million in dividends to its existing shareholders.
As of 31 May 2019, Caring has RM 153.47 million in shareholders’ equity and RM 7.77 million in non-current liabilities . Thus, its gearing ratio is 5.06%. At that time, Caring has RM 121.27 million in current liabilities and RM 243.07 million in current assets.
2019-10-21 16:12
BJ in, price most probably will move in tandem with BJ cos of which BJL and BJG are now around 20, BJM to be delisted soon, etc. Well done.
2019-10-28 18:26
Pharmaniaga's services would be extended until the Cabinet decides on the mechanism to manage the open tender.
source link: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234024.jsp
2019-11-06 14:58
Pharmaniaga Bhd witnessed a 300% spike in orders, largely from hospitals and government clinics after the government announced the firm’s drugs and medical supply concession would end on Nov 30.
Check this out!!! https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234455.jsp
2019-11-08 10:53
Caring Pharmacy Group Bhd reported a net profit of RM4.18 million for its first quarter ended Aug 31, 2019 a 2.3% increase from RM4.09 million in the same quarter of the previous year, attributed to the sales generated from the establishment of 16 new outlets.
Its revenue rose 8.9% to RM163.26 million from RM149.97 million.
2019-11-08 17:58
POSITIVE REACTION ON PHARMANIAGA EXTENSION
Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234829.jsp
2019-11-11 16:44
Check this out!!!
Sources Link:https://klse.i3investor.com/blogs/MYpharmaceuticalnews/234991.jsp
2019-11-12 11:13
PHARMANIAGA STOCK RECORD YEAR’S STRONGEST JUMP
Check this out!!!
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/235081.jsp
2019-11-12 17:21
Pharmaniaga Bhd confirms today that it has secured a five-year extension for the provision of logistics and distribution services to the Ministry of Health, to end on Dec 31, 2024.
Check this out:
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/237671.jsp
2019-11-19 11:40
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/238123.jsp
Govt extends Pharmaniaga services for medicines, medical supplies
2019-11-20 12:00
Now that govt is removing concession, its a smart move for Pharmaniaga to focus on diversifying
2019-11-22 11:10
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/240245.jsp
PHARMANIAGA MAY STILL HAVE THE UPPER HAND
2019-11-26 14:42
BJ takeover, performance will be like BJ, and from cash rich to depleting cash?
2019-11-29 08:37
Pharmaniaga is contributing to non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) to support the registration of a new treatment for those with hepatitis C in Malaysia.
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/242914.jsp
2019-12-03 09:15
Good news from Pharmaniaga!!!
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/247439.jsp
2019-12-13 14:53
Lets take a look!
https://klse.i3investor.com/blogs/MYpharmaceuticalnews/2019-12-31-story-h1481975295-PHARMANIAGA_READY_TO_FACE_2020.jsp
2019-12-31 09:33
BJ taking over is a nightmare for Caring. Tan CY and all the retail companies =koyak
2020-01-08 22:42
Just want the cash of caring? Then can announce expansion and borrow more?
2020-03-06 13:28
item price keep ....increasing... quantity keep reducing ....still we buy
2020-04-06 11:35
All pharmacy counters ... good buy, supported by covid-19
Pharmacy businesses ... got lockdown during the MCO ?
Can we see doctors n buy medicines during MCO ?
2020-04-06 11:46
Bai bai caring. Good luck, don't let vincent tan run you into the ground
2020-05-05 17:19
List & delist again. lol
https://www.forbes.com/sites/neerjajetley/2013/11/27/billionaire-vincent-tan-plays-hide-and-seek-on-the-bourse-whats-his-game-plan/#5feadf8b1fd7
2020-05-05 22:28
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
4
save malaysia!
Visa-free travel to China extended for Malaysians to 30 days
5
6
7
Good Articles to Share
8
Good Articles to Share
Four convicted in Spain over homophobic murder that sparked nationwode protests
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
kalofarmako
yup, caring is different from any pharmacy even deorg pun jual ubat-ubatan.
2019-08-22 15:46